You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • P174 Effect of continued treatment with pirfenidone following a ≥10% relative decline in percent predicted forced vital capacity (%FVC) in patients with idiopathic pulmonary fibrosis (IPF)

Article metrics

Article menu
Download PDFPDF
Treating Idiopathic Pulmonary Fibrosis
P174 Effect of continued treatment with pirfenidone following a ≥10% relative decline in percent predicted forced vital capacity (%FVC) in patients with idiopathic pulmonary fibrosis (IPF)

 

Online download statistics by month:

Online download statistics by month: November 2016 to September 2024

AbstractFullPdf
Nov 20161204
Dec 2016801
Jan 20171301
Feb 20172401
Mar 20171502
Apr 20171708
May 2017900
Jun 20171701
Jul 20172000
Aug 20171102
Sep 20173100
Oct 20172600
Nov 20171602
Dec 20172000
Jan 20181600
Feb 20181200
Mar 20182602
Apr 20181106
May 20181400
Jun 20181601
Jul 20181601
Aug 2018900
Sep 2018400
Oct 2018600
Nov 20181000
Dec 2018400
Jan 2019400
Feb 2019200
Mar 2019200
Apr 2019500
May 2019200
Jun 2019400
Jul 2019200
Aug 2019800
Sep 2019800
Oct 2019200
Nov 20191204
Dec 2019403
Jan 2020402
Feb 2020501
Mar 2020805
Apr 2020200
May 2020603
Jun 20201204
Jul 20201002
Aug 2020001
Sep 20201803
Oct 2020801
Nov 20201804
Jan 2021404
Feb 2021001
Mar 2021603
Apr 2021203
May 2021101
Jun 2021002
Jul 2021002
Aug 2021006
Sep 2021001
Oct 20216016
Nov 20212013
Dec 20211802
Jan 2022300
Feb 2022400
Mar 2022502
Apr 2022300
May 2022606
Jun 2022202
Jul 20221001
Aug 2022800
Sep 20221205
Oct 2022401
Nov 20221005
Dec 2022600
Jan 2023202
Feb 2023200
Mar 2023200
Apr 2023402
May 2023205
Jul 2023603
Aug 2023202
Sep 20231202
Oct 2023701
Nov 2023603
Dec 20232704
Jan 20241002
Feb 2024201
Mar 20246017
Apr 20241103
May 20242003
Jun 20241200
Jul 2024601
Aug 2024400
Sep 20241002
Total7940194